Reference Library: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
* [[ | * [[QIBA in the Literature Citations]] | ||
Revision as of 03:47, 12 May 2016
As content accumulates, we can think about appropriate organization.
- Guidance for Industry, Standards for Clinical Trial Imaging Endpoints, Food and Drug Administration, August 2011.
- Guidance for Industry, E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions, Food and Drug Administration, August 2011.
- Guideline on Clinical Evaluation of Diagnostic Agents, European Medicines Agency, July 2009.